Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

19 Apr 2012 07:00

RNS Number : 6286B
Persimmon PLC
19 April 2012
 



INTERIM MANAGEMENT STATEMENT

THURSDAY 19TH APRIL 2012

 

 

 

Persimmon Plc ("Persimmon" or the "Group") will hold its Annual General Meeting at 12 noon today at York Racecourse where the Chairman will make the following statement regarding current trading, financial performance and the outlook for the financial year. This statement, which supplements the update given at the time of our 2011 results, covers the period from 1st January 2012 to date and constitutes Persimmon's first Interim Management Statement in 2012.

 

As previously reported, we have experienced a strong start to the current year with the spring selling season continuing to outperform the previous year. Visitor levels to our sites over the first fifteen weeks have been c. 10% higher with cancellation rates running at historically low levels at c. 17%.

 

We continue to be encouraged by the level of customer enquiries registered on both our Persimmon Homes and Charles Church websites and we have seen a further increase in interest following the Government's launch of the NewBuy 95% loan-to-value mortgage guarantee product in March. We believe this scheme will support increased sales activity for the UK housebuilding industry once all the major mortgage lenders have entered the market, and made NewBuy widely available at attractive rates.

 

Our weekly private sales rate has continued to run ahead of the same period in the prior year increasing by c. 20% in the first fifteen weeks of the year. Our order book, including legal completions already achieved for the current year, now totals £1.24 billion, 9% ahead of the position at the same point last year.

 

In February 2012, we announced a new long-term strategy to support the development of the Group into a stronger, larger business over the next decade, whilst maximising returns from the capital we employ in the business and providing greater visibility of returns to shareholders. As part of this strategy we plan to return £1.9 billion (£6.20 per share) of capital to our shareholders over the next nine and a half years.

 

Margin improvement and cash generation remain central features of this strategy. Further progress has been made on both these measures and our more recent weeks' sales confirm that the trend of increasing profitability is continuing. Our cash position which approaches our peak working capital requirement at the end of March 2012 was c. £12 million (March 2011: £113 million borrowings). This strong cash position results from total free cash generation pre dividends of c. £151 million over the previous twelve months demonstrating continued delivery of healthy cash inflows in line with our long term strategy.

 

The new National Planning Policy Framework published on 27th March 2012 now requires local authorities to plan for the needs of their area with a presumption in favour of sustainable development. We believe this streamlined system should lead to greater speed in the delivery of planning permission once all parties understand the full implications of the Government's new framework. The focus on Localism within the process fits well with our regional teams' long record of local engagement and should assist Persimmon's ability to deliver sites from our c. 16,500 acres of strategic land, as well as helping to deliver schemes we are currently promoting.

 

Whilst the availability of mortgage credit remains the key constraint on the UK housing market, we remain confident that Persimmon can operate successfully within existing market conditions as we execute our new strategy and build a larger, stronger Persimmon over the next decade.

 

We will provide a further report on the progress the business has made in our trading update on Tuesday 3rd July 2012.

 

 

For further information, please contact:

 

 

Simon Rigby

Kevin Smith

Lindsay Noton

 

Citigate Dewe Rogerson

 

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

 

 

Persimmon plc

 

Tel: +44 (0) 20 7638 9571 on the day

Tel: +44 (0) 20 7638 9571

Tel: +44 (0) 1904 642199 thereafter

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUWSNRUOASAAR
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.